Accessibility Tools

The Department is excited to announce the activation of a trial only available at UCI: “Pembrolizumab combined with radiotherapy for metastatic sarcoma.” Based on Dr. Harris’ research, this original study is a single-arm clinical trial determining the feasibility of combination treatments, pembrolizumab and stereotactic ablative radiotherapy (SBRT) in subjects with soft-tissue sarcoma for patients who have metastatic disease initially, or recurrent or progressive disease that is not eligible for curative surgery. For additional details including enrollment information, please click here:

Office LocationContact Us

Department of Radiation Oncology

UCI Medical Center

  • UCI Chao Family Comprehensive Cancer Center

    101 The City Drive, Bldg. 23, Orange
    CA 92868-3298
    Fax: (714) 456-7170
  • UCI Health
  • UC Irvine Health School of Medicine
  • University of California Irvine